肿瘤耐药机制的研究进展
Research Progress on the Mechanism of Tumor Drug Resistance
DOI: 10.12677/ACM.2021.1112911, PDF,    科研立项经费支持
作者: 王爱敏：青海大学，青海 西宁；王烈宏：青海红十字医院，青海 西宁
关键词: 肿瘤耐药；耐药机制；Tumor Drug Resistance； Drug Resistance Mechanism
摘要: 癌症的发病率每年呈上升趋势，随着手术、放疗、化疗水平的提高，恶性肿瘤患者生存率有了较大提高，然而，在化疗过程中部分患者通过内源性或获得性机制对化疗药物产生耐受，严重制约了化疗效果，影响预后。因此，通过对肿瘤耐药机制的研究，对于制定合理的化疗方案，采取有针对性的干预措施，提高生存率至关重要。本文就导致肿瘤耐药的机制相关研究进展作一回顾性总结。
Abstract: The incidence rate of cancer is increasing every year. With the improvement of operation, radiotherapy and chemotherapy, the survival rate of malignant tumor patients has been greatly improved. However, in some chemotherapy patients, the tolerance of chemotherapeutic drugs through endogenous or acquired mechanisms has seriously restricted the effect of chemotherapy and the prognosis. Therefore, through the study of the mechanism of tumor drug resistance, it is very important to formulate a reasonable chemotherapy scheme, take targeted intervention measures and improve the survival rate. This paper reviews the research progress on the mechanism of tumor drug resistance.
文章引用：王爱敏, 王烈宏. 肿瘤耐药机制的研究进展[J]. 临床医学进展, 2021, 11(12): 6139-6142. https://doi.org/10.12677/ACM.2021.1112911

参考文献

[1] 牛星燕, 张冬萍, 彭芸花. 卵巢癌铂耐药机制及相关靶向治疗研究进展[J]. 中国妇产科临床杂志, 2020, 21(6): 661-663. [Google Scholar] [CrossRef] 
[2] 刘红, 张国楠. 宫颈癌化疗耐药相关问题[J]. 中国实用妇科与产科杂志, 2015, 31(3): 198-201.
[3] Zhu, H.Y., Luo, H., Zhang, W.W., et al. (2016) Molecular Mechanisms of Cisplatin Resistance in Cervical Cancer. Drug Design Development and Therapy, 10, 1885-1895. [Google Scholar] [CrossRef] 
[4] Chandra, J.B. and Mahitosh, M. (2021) The Emerging Roles of Exosomes in Anti-Cancer Drug Resistance and Tumor Progression: An Insight towards Tumor-Microenvironment Interaction. BBA Reviews on Cancer, 1875, Article ID: 188488. [Google Scholar] [CrossRef] [PubMed]
[5] Guan, J. and Chen, J. (2013) Mesenchymal Stem Cells in the Tumor Microenvironment. Biomedical Reports, 1, 517-521. [Google Scholar] [CrossRef] [PubMed]
[6] Ruffell, B., et al. (2014) Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic Cells. Cancer Cell, 26, 623-637. [Google Scholar] [CrossRef] [PubMed]
[7] Qiao, Y., et al. (2018) IL6 Derived from Cancer-Associated Fibroblasts Promotes Chemoresistance via CXCR7 in Esophageal Squamous Cell Carcinoma. Oncogene, 37, 873-883. [Google Scholar] [CrossRef] [PubMed]
[8] Chen, C., et al. (2018) Autophagy and Doxorubicin Resistance in Cancer. Anti-Cancer Drugs, 29, 1-9. [Google Scholar] [CrossRef] 
[9] Lin, J.F., et al. (2017) Cisplatin Induces Protective Autophagy through Activation of BECN1 in Human Bladder Cancer Cells. Drug Design, Development and Therapy, 11, 1517-1533. [Google Scholar] [CrossRef] 
[10] Dixon, S., Lemberg, K., Lamprecht, M., et al. (2012) Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death. Cell, 149, 1060-1072. [Google Scholar] [CrossRef] [PubMed]
[11] Guo, J., Xu, B., Han, Q., et al. (2018) Ferroptosis: A Novel Anti-Tumor Action for Cisplatin. Cancer Research and Treatment, 50, 445-460. [Google Scholar] [CrossRef] [PubMed]
[12] Yu, Y., Xie, Y., Cao, L., et al. (2015) The Ferroptosis Inducer Erastin Enhances Sensitivity of Acute Myeloid Leukemia Cells to Chemotherapeutic Agents. Molecular & Cellular Oncology, 2, e1054549. [Google Scholar] [CrossRef] [PubMed]
[13] Roh, J.L., Kim, E.H., Jang, H., et al. (2016) Induction of Ferroptotic Cell Death for Overcoming Cisplatin Resistance of Head and Neck Cancer. Cancer Letters, 381, 96-103. [Google Scholar] [CrossRef] [PubMed]
[14] Xie, Y., Hou, W., Song, X., et al. (2016) Ferroptosis: Process and Function. Cell Death & Differentiation, 23, 369-379. [Google Scholar] [CrossRef] [PubMed]
[15] Sun, X., Niu, X., Chen, R., et al. (2016) Metallothionein-1G Facilitates Sorafenib Resistance through Inhibition of Ferroptosis. Hepatology, 64, 488-500. [Google Scholar] [CrossRef] [PubMed]
[16] 周婷, 刘荣华, 袁明. 内质网蛋白29在人上皮性卵巢癌顺铂化疗耐药中的作用[J]. 华中科技大学学报(医学版), 2021, 50(4): 466-470.
[17] Mohammad, I.S., He, W. and Yin, L.F. (2018) Understanding of Human ATP Binding Cassette Superfamily and Novel Multidrug Resistance Modulators to Overcome MDR. Biomedicine & Pharmacotherapy, 100, 335-348. [Google Scholar] [CrossRef] [PubMed]
[18] 李奕欣, 蔡云丽, 刘洋, 谷春明, 朱可心, 饶宇勋, 张昭阳. YB-1在肿瘤耐药过程中发挥的作用[J]. 湖北医药学院学报, 2020, 39(6): 629-634.
[19] Lee, W.-K. and Thévenod, F. (2019) Oncogenic PITX2 Facilitates Tumor Cell Drug Resistance by Inverse Regulation of hOCT3/SLC22A3 and ABC Drug Transporters in Colon and Kidney Cancers. Cancer Letters, 449, 237-251. [Google Scholar] [CrossRef] [PubMed]
[20] 汪洋, 柳明杰. STAT5基因沉默及过表达对人乳腺癌细胞株紫杉醇耐药性的影响及其机制[J]. 中国生物制品学杂志, 2020, 33(7): 754-761.
[21] 左兴盛, 宋志玉, 贾海盼, 付中华, 王振基, 马培志. 沉默circPVT1对5-氟尿嘧啶耐药胃癌细胞化疗增敏作用及机制研究[J]. 天津医科大学学报, 2021, 27(6): 574-579+585.
[22] Bierie, B., et al. (2017) Integrin-β4 Identifies Cancer Stem Cell-Enriched Populations of Partially Mesenchymal Carcinoma Cells. Proceedings of the National Academy of Sciences of the United States of America, 114, E2337-E2346. [Google Scholar] [CrossRef] [PubMed]
[23] McConkey, D.J., et al. (2009) Role of Epithelial-to-Mesenchymal Transition (EMT) in Drug Sensitivity and Metastasis in Bladder Cancer. Cancer Metastasis Reviews, 28, 335-344. [Google Scholar] [CrossRef] [PubMed]
[24] Anuja, K., et al. (2019) Radiation-Induced DNA Damage Response and Resistance in Colorectal Cancer Stem-Like Cells. International Journal of Radiation Biology, 95, 667-679. [Google Scholar] [CrossRef] [PubMed]
[25] Li, L., et al. (2016) Overexpression of β-Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma. BioMed Research International, 2016, Article ID: 5378567. [Google Scholar] [CrossRef] [PubMed]

为你推荐